Asln 004 2b

「Asln 004 2b」熱門搜尋資訊

「Asln 004 2b」文章包含有：「AdultsWithModeratetoSevereAtopicDermatitis」、「ASLANPharmaceuticalsInitiatesPhase2bStudyof...」、「InvestorRelations」、「News&Publications」、「未上市」、「若2022年中將亞獅康的市值帶上10億美金，您就是卓越的CEO」

Provide From Google

Adults With Moderate to Severe Atopic Dermatitis

https://www.clinicaltrials.gov

沒有這個頁面的資訊。

Provide From Google

ASLAN Pharmaceuticals Initiates Phase 2b Study of ...

https://www.biospace.com

ASLAN Pharmaceuticals Initiates Phase 2b Study of ASLAN004 (Eblasakimab) in Moderate-to-Severe Atopic Dermatitis. Published: Jan 20, 2022.

Provide From Google

Investor Relations

https://ir.aslanpharma.com

ASLAN Pharmaceuticals Initiates Phase 2b Study of ASLAN004 (Eblasakimab) in Moderate-to-Severe Atopic Dermatitis.

Provide From Google

News & Publications

https://aslanpharma.com

ASLAN Pharmaceuticals initiates Phase 2b study of ASLAN004 (eblasakimab) in moderate-to-severe atopic dermatitis. ASLAN Pharmaceuticals (Nasdaq: ASLN) has ...

Provide From Google